Forster Eliot bought PLX
September 3, 2025 · Form 4 insider transaction
Forster Eliot bought 15,000 shares of Protalix BioTherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$0.00
Total value
N/A
InsiderForster Eliot
RoleDirector
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2025
Filing dateSeptember 4, 2025
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant.; Does not include options to purchase 85,715 shares of common stock at an exercise price equal to $1.75 per share that expire on September 14, 2033,